These Form 3 filings are routine and do not indicate any trading activity or change in outlook. Monitor for future Form 4 filings if insiders begin buying or selling shares, which would provide a more actionable signal.
Price Chart
Executive Summary
Three directors of Seaport Therapeutics (SPTX) filed initial statements of beneficial ownership (Form 3) on April 30, 2026, disclosing their holdings. Steven M. Paul directly owns 796,000 shares of common stock and holds options to buy 1,674,753 shares. James I. Healy, through Sofinnova Venture Partners XI, L.P., beneficially owns 2,731,538 shares of common stock (on an as-converted basis). David Wheadon holds options to buy 89,300 shares. These filings are routine insider onboarding disclosures and contain no material financial data or trading activity.
Key Facts
- Steven M. Paul directly owns 796,000 shares of common stock and holds options to purchase 1,674,753 shares at exercise prices of $3.05, $7.39, and $10.31.
- James I. Healy, through Sofinnova Venture Partners XI, L.P., beneficially owns 1,927,159 shares of Series A-2 Preferred Stock and 804,379 shares of Series B Preferred Stock, convertible into common stock on a one-for-3.1407 basis.
- David Wheadon holds options to purchase 77,042 shares at $3.05 and 12,258 shares at $10.30.
- All three individuals serve as directors of Seaport Therapeutics, a pharmaceutical preparations company.
- The Series B Preferred Stock automatically converts to common stock upon the closing of the issuer's initial public offering.
Financial Impact
No financial impact — these are initial ownership disclosures with no transaction activity.
Risk Factors
- No material risks identified from these filings.
Investment Themes
Documents Analyzed
This report is based on 12 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 3 Filing (SPTX) — Batch item 1 | 0001193125-26-198507 |
| Document: 0001193125-26-198507-index-headers.html | 0001193125-26-198509 |
| Document: 0001193125-26-198507-index.html | 0001193125-26-198510 |
| Document: 0001193125-26-198507.txt | 0001193125-26-198507 |
| 3 Filing (SPTX) — Batch item 5 | 0001193125-26-198509 |
| Document: 0001193125-26-198509-index-headers.html | 0001193125-26-198507 |
| Document: 0001193125-26-198509-index.html | 0001193125-26-198507 |
| Document: 0001193125-26-198509.txt | 0001193125-26-198507 |
| 3 Filing (SPTX) — Batch item 9 | 0001193125-26-198510 |
| Document: 0001193125-26-198510-index-headers.html | 0001193125-26-198507 |
| Document: 0001193125-26-198510-index.html | 0001193125-26-198507 |
| Document: 0001193125-26-198510.txt | 0001193125-26-198507 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 3, 2026 12w ago | 8-K | $20.65 | awaiting T+60 | — | $20.83 (+0.87%) |
Jun 8, 2026 20w ago | 8-K | $16.20 $23.61 | ▲ +45.74% | ▲ +42.69% | $20.83 (+28.58%) |
May 6, 2026 24w ago | 3 | $15.50 $20.65 | ▲ +33.23% | ▲ +29.39% | $20.83 (+34.39%) |
May 1, 2026 25w ago | 424B4 | $17.00 $19.74 | ▲ +16.12% | ▲ +14.26% | $20.83 (+22.53%) |
Apr 30, 2026 25w ago | 3 | $19.84 $19.90 | ▲ +0.30% | ▼ −2.77% | $20.83 (+4.99%) |
Apr 30, 2026 25w ago | 3 | $19.84 $19.90 | ▲ +0.30% | ▼ −2.77% | $20.83 (+4.99%) |
Apr 30, 2026 25w ago | 3 | $19.84 $19.90 | ▲ +0.30% | ▼ −2.77% | $20.83 (+4.99%) |
Apr 30, 2026 25w ago | 3 | $19.84 $19.90 | ▲ +0.30% | ▼ −2.77% | $20.83 (+4.99%) |
Apr 30, 2026 25w ago | 3 | $19.84 $19.90 | ▲ +0.30% | ▼ −2.77% | $20.83 (+4.99%) |
Apr 27, 2026 26w ago | S-1/A | — | awaiting T+60 | — | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers